US equities |
GOOGL $283.15 ▼-12.85% GOOG $281.02 ▼-12.70% MSFT $525.72 ▼-1.00% META $626.61 ▲+2.30% MU $937.80 ▼-4.62% NVDA $213.42 ▼-0.91% AMZN $245.85 ▼-3.44% AAPL $349.61 ▲+1.68%
FinancialContent

Atossa Therapeutics, Inc. - Common Stock (NQ:ATOS)

2.305 -0.065 (-2.74%)
Delayed Quote Updated: 1:27 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Atossa Therapeutics, Inc. - Common Stock

News headline image
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
Issued on behalf of Oncolytics Biotech Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
Via ACCESS Newswire
News headline image
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
News headline image
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
Via ACCESSWIRE
News headline image
50% Of Women Have Elevated Breast Density, Which Significantly Decreases the Effectiveness of Mammography - Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
Via ACCESSWIRE